Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic interventions in acute stroke.

K R Lees1

  • 1University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow.

British Journal of Clinical Pharmacology
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and outcomes of routine endovascular thrombectomy in large artery occlusion recorded in the SITS Register: An observational study.

Journal of internal medicine·2021
Same author

Small vessel disease and clinical outcomes after IV rt-PA treatment.

Acta neurologica Scandinavica·2017
Same author

Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists.

The journal of the Royal College of Physicians of Edinburgh·2016
Same author

Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack.

European journal of neurology·2016
Same author

Impact of heart rate on admission on mortality and morbidity in acute ischaemic stroke patients - results from VISTA.

European journal of neurology·2016
Same author

Determinants of post-stroke cognitive impairment: analysis from VISTA.

Acta neurologica Scandinavica·2016
Same journal

Development of a population pharmacokinetic model using combined paediatric and adult data for four pulmonary arterial hypertension drugs.

British journal of clinical pharmacology·2026
Same journal

Case-malformed signal detection and prioritisation using EUROmediCAT data for pharmacovigilance in pregnancy.

British journal of clinical pharmacology·2026
Same journal

ACEi/ARB in adults older than 85 years after AKI: Beyond single-drug paradigm to phenotype-guided care.

British journal of clinical pharmacology·2026
Same journal

Do consumers and healthcare professionals report the same adverse event differently? A paired analysis of duplicate vaccine safety reports in Norway.

British journal of clinical pharmacology·2026
Same journal

Predicting cognitive function in Alzheimer's clinical trials via amyloid β-protein biomarkers.

British journal of clinical pharmacology·2026
Same journal

Comparative effectiveness of dapagliflozin vs. empagliflozin on major adverse cardiovascular events in patients with heart failure with reduced ejection fraction: A real-world prospective cohort study.

British journal of clinical pharmacology·2026
See all related articles

Investigating acute ischemic stroke treatments, this study found that while some therapies like steroids and glycerol are ineffective, neuronal cytoprotection shows promise. Successful stroke treatment likely requires combining multiple approaches and rigorous clinical trial designs.

Area of Science:

  • Neurology
  • Cerebrovascular Medicine
  • Pharmacology

Background:

  • Ischemic stroke treatment aims to reduce edema, improve perfusion, mitigate excitotoxicity, and prevent complications.
  • Existing therapies like steroids and intravenous glycerol for edema are ineffective or unproven.
  • Hemodilution to improve perfusion has shown ineffectiveness.

Purpose of the Study:

  • To review potential therapeutic agents for acute ischemic stroke.
  • To evaluate the efficacy and limitations of current and emerging stroke treatments.
  • To highlight the essential components for successful clinical trials in stroke.

Main Methods:

  • Review of existing literature on ischemic stroke therapies.
  • Analysis of the effectiveness of agents targeting edema, perfusion, excitotoxicity, and free-radical injury.

Related Experiment Videos

  • Discussion of the design requirements for future therapeutic trials.

    • Main Results:

    • Steroids and intravenous glycerol are ineffective for edema.
    • Hemodilution is ineffective for improving perfusion.
    • Neuronal cytoprotective agents (glutamate antagonists, channel blockers, free radical scavengers) show experimental promise and are entering clinical trials.
    • Thrombolytic, anticoagulant, and antiplatelet drugs require further testing in large-scale, randomized trials.

    Conclusions:

    • Acute ischemic stroke treatment is likely to involve a combination of therapeutic strategies.
    • Future stroke trials must incorporate early treatment initiation, computed tomography (CT) scanning, and a multicenter approach to ensure adequate patient numbers and reliable results.